CANGZHOU CITY, HEBEI, CHINA, January 20, 2026 /EINPresswire.com/ -- In a rapidly evolving global infrastructure and ...
Co., Ltd, recognized as a leading seamless steel pipe manufacturer, has strategically expanded its portfolio to include ...
Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.
Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion ...
Guyana is rapidly pursuing a second gas pipeline project to utilize its offshore associated gas as a "bridge" to anchor a broader domestic industrial base and convert its oil windfall into long-term ...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") today reported its financial and operating results ...
Royalty Pharma’s valuation remains attractive, supported by sector momentum and sustained capital returns. Click here to know ...
Nextensa closed the 2025 financial year with strong results, confirming a clear increase in profitability (+€33.8 M) driven ...
State-run energy giant ONGC is moving to unlock its $550 million dividend backlog in Venezuela as US sanctions ease.
As the pace of change accelerates in early 2026, technical decision-makers are faced with a fundamental choice between ...
Bayer Aktiengesellschaft ( BAYRY) Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate ...
Tempest outlines a capital-efficient post-transaction strategy to advance a diversified portfolio of next-generation CAR-T and oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results